Performance of DNA Methylation on the Molecular Pathogenesis of Helicobacter pylori in Gastric Cancer; targeted therapy approach

키워드

참고문헌 (72)

1. Rawla P, "Epidemiology of gastric cancer : global trends, risk factors and prevention", Prz Gastroenterol, 14(1), pp.26~38 (2019)
2. Pucułek M, "Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype", Oncotarget, 9(57), pp.31146~31162 (2018)
3. Nicolescu F, "Trends in Helicobacter pylori infection", pp.177~ (2014), IntechOpen
4. Huang Y, "Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori", Front Cell Infect Microbiol, 6, pp.159~ (2016)
5. Tilahun M, "Helicobacter pylori pathogenicity islands and Giardia lamblia cysteine proteases in role of coinfection and pathogenesis", Infect Drug Resist, 15, pp.21~34 (2022)
6. Conteduca V, "pylori infection and gastric cancer : state of the art(review)", Int J Oncol, 42(1), pp.5~18 (2013)
7. Baj J, "Helicobacter pylori virulence factors-mechanisms of bacterial pathogenicity in the gastric microenvironment", Cells, 10(1), pp.27~ (2020)
8. Toh JWT, "Pathways of gastric carcinogenesis, Helicobacter pylori virulence and interactions with antioxidant systems, vitamin C and phytochemicals", Int J Mol Sci, 21(17), pp.6451~ (2020)
9. White JR, "Differential inflammatory response to Helicobacter pylori infection : etiology and clinical outcomes", J Inflamm Res, 8, pp.137~147 (2015)
10. Zhang Y, "One stomach, two subtypes of carcinoma-the differences between distal and proximal gastric cancer", Gastroenterol Rep(Oxf), 9(6), pp.489~504 (2021)
11. Pourzardosht N, "Liothyronine could block the programmed death-ligand 1 (PDL1) activity: an e-Pharmacophore modeling and virtual screening study", J Recept Signal Transduct Res, 42(1), pp.34~42 (2022)
12. Graham DY, "Helicobacter pylori update : gastric cancer, reliable therapy, and possible benefits", Gastroenterology, 148(4), pp.719~731.e3 (2015)[DOI]
13. Matsuo Y, "Helicobacter pylori outer membrane protein-related pathogenesis", Toxins (Basel), 9(3), pp.101~ (2017)
14. Yamaoka Y, "Helicobacter pylori virulence and cancer pathogenesis", Future Oncol, 10(8), pp.1487~1500 (2014)
15. Tegtmeyer N, "Type IV secretion of Helicobacter pylori CagA into oral epithelial cells is prevented by the absence of CEACAM receptor expression", Gut Pathog, 12, pp.25~ (2020)
16. Matos JI, "Helicobacter pylori CagA and VacA genotypes and gastric phenotype : a meta-analysis", Eur J Gastroenterol Hepatol, 25(12), pp.1431~1441 (2013)
17. Amin M, "Concurrent detection of cagA, vacA , sodB and hsp60 virulence genes and their relationship with clinical outcomes of disease in Helicobacter pylori isolated strains of southwest of Iran", Iran J Microbiol, 11(3), pp.198~205 (2019)
18. Queiroz DM, "Higher frequency of cagA EPIYA-C phosphorylation sites in H. pylori strains from first-degree relatives of gastric cancer patients", BMC Gastroenterol, 12(1), pp.107~ (2012)
19. Oluwasola A, "Correlation of serum anti-Helicobacter pylori immunoglobulin a(IgA)with histological parameters of chronic gastritis in ibadan, Nigeria", Ann Ib Postgrad Med, 10(1), pp.18~24 (2012)
20. Foegeding NJ, "An overview of Helicobacter pylori VacA toxin biology", Toxins (Basel), 8(6), pp.173~ (2016)
21. Abbasi O, "Soluble VEGFR1 concentration in the serum of patients with colorectal cancer", Surg Today, 45(2), pp.215~220 (2015)
22. Baj J, "Mechanisms of the epithelial-mesenchymal transition and tumor microenvironment in Helicobacter pylori-induced gastric cancer", Cells, 9(4), pp.1055~ (2020)
23. Dewayani A, "The roles of IL-17, IL-21, and IL-23 in the Helicobacter pylori infection and gastrointestinal inflammation : a review", Toxins (Basel), 13(5), pp.315~ (2021)
24. Meliț LE, "The relationship between toll-like receptors and Helicobacter pylori-related gastropathies : still a controversial topic", J Immunol Res, 2019, pp.8197048~ (2019)
25. Shimomura H, "Unique responses of Helicobacter pylori to exogenous hydrophobic compounds", Chem Phys Lipids, 229, pp.104908~ (2020)
26. Mirzaei R, "Immunometabolism in biofilm infection : lessons from cancer", Mol Med, 28(1), pp.10~ (2022)
27. Hernández-Rubio A, "Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder", Sci Rep, 10(1), pp.20060~ (2020)
28. Vahidi S, "TERRA gene expression in gastric cancer : role of hTERT", J Gastrointest Cancer, 52(2), pp.431~447 (2021)
29. Vahidi S, "DNA methylation profiling of hTERT gene alongside with the telomere performance in gastric adenocarcinoma", J Gastrointest Cancer, 51(3), pp.788~799 (2020)
30. Muhammad JS, "Helicobacter pylori-induced DNA methylation as an epigenetic modulator of gastric cancer : recent outcomes and future direction", Pathogens, 8(1), pp.23~ (2019)
31. Huang FY, "Characterization of interleukin-1β in Helicobacter pylori -induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1(-", -)) mice, 2013, pp.49(12), 2760~2770
32. 나혜경, "Helicobacter pyloriInduces Hypermethylation of CpG Islands Through Upregulation of DNA Methyltransferase: Possible Involvement of Reactive Oxygen", Nitrogen Species, 2014, pp.19(4), 259~264[DOI]
33. Polakovicova I, "Role of microRNAs and exosomes in Helicobacter pylori and Epstein-Barr virus associated gastric cancers", Front Microbiol, 9, pp.636~ (2018)
34. Rizzato C, "Variations in cag pathogenicity island genes of Helicobacter pylori from Latin American groups may influence neoplastic progression to gastric cancer", Sci Rep, 10(1), pp.6570~ (2020)
35. Hayashi Y, "CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis", Gut, 62(11), pp.1536~1546 (2013)
36. Ricci V, "Relationship between VacA toxin and host cell autophagy in Helicobacter pylori infection of the human stomach : a few answers, many questions", Toxins (Basel), 8(7), pp.203~ (2016)
37. Norollahi SE, "Regulatory fluctuation of WNT16 gene expression is associated with human gastric adenocarcinoma", J Gastrointest Cancer, 50(1), pp.42~47 (2019)
38. Whyte JM, "Best practices in DNA methylation : lessons from inflammatory bowel disease, psoriasis and ankylosing spondylitis", Arthritis Res Ther, 21(1), pp.133~ (2019)
39. Zhang B, "CagA increases DNA methylation and decreases PTEN expression in human gastric cancer", Mol Med Rep, 19(1), pp.309~319 (2019)
40. Pizarro-Cerdá J, "The diverse family of Arp2", 3 complexes, 2017, pp.27(2), 93~100
41. Demidchik V, "Calcium transport across plant membranes : mechanisms and functions", New Phytol, 220(1), pp.49~69 (2018)
42. Costa L, "USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis", Gut, 69(9), pp.1582~1591 (2020)
43. Wang Y, "Connexin 32 and 43 promoter methylation in Helicobacter pylori-associated gastric tumorigenesis", World J Gastroenterol, 20(33), pp.11770~11779 (2014)
44. Hoffmann W, "Trefoil factor family(TFF)peptides and their diverse molecular functions in mucus barrier protection and more : changing the paradigm", Int J Mol Sci, 21(12), pp.4535~ (2020)
45. Funato N, "The transcription factor HAND1 is involved in cortical bone mass through the regulation of collagen expression", Int J Mol Sci, 21(22), pp.8638~ (2020)
46. Lu XX, "Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression", Cancer, 118(22), pp.5507~5517 (2012)
47. Uehara S, "Non-canonical Wnt signals regulate cytoskeletal remodeling in osteoclasts", Cell Mol Life Sci, 75(20), pp.3683~3692 (2018)
48. Zhu ZJ, "Virusencoded miR-155 ortholog in Marek’s disease virus promotes cell proliferation via suppressing apoptosis by targeting tumor suppressor WWOX", Vet Microbiol, 252, pp.108919~ (2021)
49. Hatzistergos KE, "Tumor suppressors RB1 and CDKN2a cooperatively regulate cell-cycle progression and differentiation during cardiomyocyte development and repair", Circ Res, 124(8), pp.1184~1197 (2019)
50. Murakami M, "Updating phospholipase A2biology", Biomolecules, 10(10), pp.1457~ (2020)
51. Lork M, "CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death : so similar, yet so different", Cell Death Differ, 24(7), pp.1172~1183 (2017)
52. Ye M, "Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy", Pharmacol Ther, 215, pp.107633~ (2020)
53. Alvarez MC, "MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults", World J Gastroenterol, 19(20), pp.3043~3051 (2013)
54. Ye Y, "COX-2-PGE2-EPs in gynecological cancers", Arch Gynecol Obstet, 301(6), pp.1365~1375 (2020)
55. Alvarez MC, "Effect of Helicobacter pylori infection on GATA-5 and TFF1 regulation, comparison between pediatric and adult patients", Dig Dis Sci, 63(11), pp.2889~2897 (2018)
56. Cheng AS, "Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis", Gastroenterology, 144(1), pp.122~133.e9 (2013)
57. Tanaka S, "Autophagy-related genes in Helicobacter pylori infection", Helicobacter, 22(3), pp.e12376~ (2017)
58. Miao R, "VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer", PLoS One, 8(9), pp.e74409~ (2013)
59. Mashayekhi S, "Effects of miR-27a, miR-196a2 and miR-146a polymorphisms on the risk of breast cancer", Br J Biomed Sci, 75(2), pp.76~81 (2018)
60. Prinz C, "MicroRNA (miR) dysregulation during Helicobacter pylori -induced gastric inflammation and cancer development: critical importance of miR-155", Oncotarget, 11(10), pp.894~904 (2020)
61. Yang Y, "Host miRNAs-microbiota interactions in gastric cancer", J Transl Med, 20(1), pp.52~ (2022)
62. Xie WQ, "MiR-146a rs2910164 polymorphism increases risk of gastric cancer : a meta-analysis", World J Gastroenterol, 20(41), pp.15440~15447 (2014)
63. Ebrahimi Ghahnavieh L, "Fluctuating expression of miR-584 in primary and high-grade gastric cancer", BMC Cancer, 20(1), pp.621~ (2020)
64. Chu DT, "Recent progress of stem cell therapy in cancer treatment : molecular mechanisms and potential applications", Cells, 9(3), pp.563~ (2020)
65. Peek RM Jr, "Role of innate immunity in Helicobacter pylori-induced gastric malignancy", Physiol Rev, 90(3), pp.831~858 (2010)
66. van Putten JPM, "Transmembrane mucins : signaling receptors at the intersection of inflammation and cancer", J Innate Immun, 9(3), pp.281~299 (2017)
67. He Y, "Sustained exposure to Helicobacter pylori lysate inhibits apoptosis and autophagy of gastric epithelial cells", Front Oncol, 10, pp.581364~ (2020)
68. Yamamoto H, "BARHL2 methylation using gastric wash DNA or gastric juice exosomal DNA is a useful marker for early detection of gastric cancer in an H. pylori -independent manner", Clin Transl Gastroenterol, 7(7), pp.e184~ (2016)
69. Schneider BG, "DNA methylation predicts progression of human gastric lesions", Cancer Epidemiol Biomarkers Prev, 24(10), pp.1607~1613 (2015)
70. Asada K, "Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study", Gut, 64(3), pp.388~396 (2015)
71. Zhao R, "Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism", Cancer Med, 9(7), pp.2551~2563 (2020)
72. Tahara T, "Prostate stem cell antigen gene polymorphism is associated with H. pylori -related promoter DNA methylation in nonneoplastic gastric epithelium", Cancer Prev Res (Phila), 12(9), pp.579~584 (2019)

관련 논문AI추천